Previous studies have shown that HNRNPA2B1 is overexpressed in breast cancer tissue, and that its encoded protein can activate the STAT3 and ERK1/2 signaling pathways, thereby promoting the tumorigenic potential of cancer cells. This evidence concerns the gene MAPK3 and breast carcinoma.